In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation

Brain Research

Volumn 900, Issue 1, 2001, Pages 72-79

  Cormier, Anne ^a   Morin, Christophe ^a   Zini, Roland ^a   Tillement, Jean Paul ^a   Lagrue, Gilbert ^b  

^a FACULTÉ DE MÉDECINE   (France)

^b Hopital Albert Chenevier   (France)

Author keywords

Mitochondria; Nicotine; Respiratory chain; Superoxide anion

Indexed keywords

COTININE; NICOTINE; NORNICOTINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BRAIN MITOCHONDRION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; IN VITRO STUDY; MITOCHONDRIAL RESPIRATION; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN;

ADENOSINE TRIPHOSPHATASES; ALKALOIDS; ANIMALS; ANTHRAQUINONES; ANTIMYCIN A; AZOCINES; BICYCLO COMPOUNDS, HETEROCYCLIC; CARRIER PROTEINS; COTININE; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX II; HEXAMETHONIUM; MALE; MEMBRANE PROTEINS; MITOCHONDRIA; MULTIENZYME COMPLEXES; NAD; NADH, NADPH OXIDOREDUCTASES; NEUROPROTECTIVE AGENTS; NICOTINE; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; OXIDOREDUCTASES; OXYGEN CONSUMPTION; PROSENCEPHALON; PYRIDINES; QUINOLIZINES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, NICOTINIC; ROTENONE; SUCCINATE DEHYDROGENASE; SUPEROXIDES; SYNAPTOSOMES;

EID: 0035805115     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02254-5     Document Type: Article

References (34)

1. Almeida A., Brooks K.J., Sammut I., Keelan J., Davey G.P., Clark J.B., Bates T.E. Postnatal development of the complexes of the electron transport chain in synaptic mitochondria from rat brain. Dev. Neurosci. 17:1995;212-218.
2. Anderson D.J., Arneric S.P. Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain. Eur. J. Pharmacol. 253:1994;261-267.
3. Benowitz N.L. Clinical pharmacology of nicotine. Annu. Rev. Med. 37:1986;21-32. Review.
4. Benowitz N.L., Jacob P. 3rd, Fong I., Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther. 268:1994;296-303.
5. Bhagwat S.V., Vijayasarathy C., Raza H., Mullick J., Avadhani N.G. Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. Biochem. Pharmacol. 56:1998;831-839.
6. Clarke P.B., Fu D.S., Jakubovic A., Fibiger H.C. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J. Pharmacol. Exp. Ther. 246:1988;701-708.
7. Crooks P.A., Li M., Dwoskin L.P. Metabolites of nicotine in rat brain after peripheral nicotine administration. Cotinine, nornicotine, and norcotinine. Drug Metab. Dispos. 25:1997;47-54.
8. Damaj M.I., Welch S.P., Martin B.R. In vivo pharmacological effects of dihydro-beta-erythroidine, a nicotinic antagonist, in mice. Psychopharmacology (Berl). 117:1995;67-73.
9. Degli Esposti M. Inhibitors of NADH-ubiquinone reductase: an overview. Biochim. Biophys. Acta. 1364:1998;222-235. Review.
10. U.S. Department of Health and Human Services, Public Health Service. 1988. The Health Consequances of Smoking: Nicotine Addiction: a report of the Surgeon General. U.S. Government Printing Office, Washington, D.C. DHHS Publication No. (CDC) 88-8406.
11. Dursun S.M., Kutcher S. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research. Med. Hypotheses. 52:1999;101-109. Review.
12. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 66:1925;375-400.
13. Fratiglioni L., Wang H. Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies. Behav. Brain Res. 113:2000;117-120.
14. Hasegawa K., Yoshioka H., Sawada T., Nishikawa H. Direct measurement of free radicals in the neonatal mouse brain subjected to hypoxia: an electron spin resonance spectroscopic study. Brain Res. 607:1993;161-166.
15. Hoffmann D., Hecht S.S., Wynder E.L. Tumor promoters and cocarcinogens in tobacco carcinogenesis. Environ. Health Perspect. 50:1983;247-257.
16. Keller J.N., Mark R.J., Bruce A.J., Blanc E., Rothstein J.D., Uchida K., Waeg G., Mattson M.P. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience. 80:1997;685-696.
17. Kogan M.J., Verebey K., Jaffee J.H., Mule S.J. Simultaneous determination of nicotine and cotinine in human plasma by nitrogen detection gas-liquid chromatography. J. Forensic. Sci. 26:1981;6-11.
18. Kristian T., Ouyang Y., Siesjo B.K. Calcium-induced neuronal cell death in vivo and in vitro: are the pathophysiologic mechanisms different? Adv. Neurol. 71:1996;107-113.
19. Lindstrom J. Nicotinic acetylcholine receptors in health and disease. Mol. Neurobiol. 15:1997;193-222. Review.
20. Linert W., Bridge M.H., Huber M., Bjugstad K.B., Grossman S., Arendash G.W. In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases. Biochim. Biophys. Acta. 1454:1999;143-152.
21. Mack T.M., Yu M.C., Hanisch R., Henderson B.E. Pancreas cancer and smoking, beverage consumption, and past medical history. J. Natl. Cancer Inst. 76:1986;49-60.
22. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
23. Newhouse P.A., Potter A., Levin E.D. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging. 11:1997;206-228. Review.
24. Olanow C.W., Arendash G.W. Metals and free radicals in neurodegeneration. Curr. Opin. Neurol. 7:1994;548-558. Review.
25. Pryor W.A., Arbour N.C., Upham B., Church D.F. The inhibitory effect of extracts of cigarette tar on electron transport of mitochondria and submitochondrial particles. Free Radic. Biol. Med. 12:1992;365-372.
26. Quirion R., Richard J., Wilson A. Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats. Synapse. 17:1994;92-100.
27. Rowell P.P., Winkler D.L. Nicotinic stimulation of [3H]acetylcholine release from mouse cerebral cortical synaptosomes. J. Neurochem. 43:1984;1593-1598.
28. Russell M.A., Jarvis M., Iyer R., Feyerabend C. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br. Med. J. 280:1980;972-976.
29. Simon N., Zini R., Morin C., Bree F., Tillement J.P. Prednisolone and azathioprine worsen the cyclosporine A-induced oxidative phosphorylation decrease of kidney mitochondria. Life Sci. 61:1997;659-666.
30. Sims N.R. Rapid isolation of metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugation. J. Neurochem. 55:1990;698-707.
31. Urien S. MicroPharm-K, a microcomputer interactive program for the analysis and simulation of pharmacokinetic processes. Pharm. Res. 12:1995;1225-1230.
32. Wetscher G.J., Bagchi M., Bagchi D., Perdikis G., Hinder P.R., Glaser K., Hinder R.A. Free radical production in nicotine treated pancreatic tissue. Free Radic. Biol. Med. 18:1995;877-882.
33. Wonnacott S., Irons J., Rapier C., Thorne B., Lunt G.G. Presynaptic modulation of transmitter release by nicotinic receptors. Prog. Brain Res. 79:1989;157-163.
34. Xiao Y., Meyer E.L., Thompson J.M., Surin A., Wroblewski J., Kellar K.J. Rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol. Pharmacol. 54:1998;322-333.